ArticleScientific reports2020

Pharmacological and genetic targeting of 5-lipoxygenase interrupts c-Myc oncogenic signaling and kills enzalutamide-resistant prostate cancer cells via apoptosis.

Jitender Monga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.